Acquired by e-MSion was acquired by Agilent Technologies in March 2023, indicating potential access to Agilent’s distributor channels, customer base, and complementary product lines.

ExD Cell Value The ExD Cell offers electron-based dissociation for mass spectrometry, presenting opportunities to cross-sell to life sciences researchers and drug development teams seeking advanced protein characterization capabilities.

Mid-market footprint With 11-50 employees and annual revenue in the low millions, e-MSion operates as a small, agile innovator suitable for targeted enterprise collaborations or pilots with larger lab instrument manufacturers.

Academic-to-Industry Originating from university collaboration and now serving academic researchers and drug manufacturers, there is a clear path for partnerships with universities, contract research organizations, and pharma companies pursuing advanced MS techniques.

Growth trajectory A growing technical team and specialized mass spectrometry expertise suggest scalable solutions and potential for expanded product adoption through training programs, field service partnerships, and expanded support offerings.